.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Teva
Colorcon
McKesson
Deloitte
Chubb
Cipla
Queensland Health
Accenture

Generated: July 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,431,615

« Back to Dashboard

Claims for Patent: 8,431,615

Title:Dose forms
Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
Inventor(s): Chu; Hui-May (Natick, MA), Ette; Ene (Framingham, MA), McNair; Lindsay (Allston, MA), Alam; John (Cambridge, MA)
Assignee: Vertex Pharmaceuticals Incorporated (Cambridge, MA)
Application Number:11/264,746
Patent Claims: 1. A therapeutic regimen comprising administering for a period of at least 14 days: a. VX-950, or a pharmaceutically acceptable salt thereof, three times per day in an amount of about 750 mg; b. pegylated interferon in an amount of about 180 .mu.g/wk; and c. ribavirin.

2. The regimen of claim 1, wherein the amount of VX-950 is administered every 8 hours.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Express Scripts
Deloitte
Boehringer Ingelheim
Healthtrust
Teva
US Army
Novartis
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot